Familial CD45RA– T cells to treat severe refractory infections in immunocompromised patients

Abstract

The use of familial CD45RA^- T-cells containing specific Cytotoxic T-lymphocytes is a feasible, safe and potential effective approach for treating severe pathogen infections in immunocompromised patients through a third party donor. Furthermore, this approach might be of universal use with fewer institutional and regulatory barriers.